Investing.com - Biohaven Pharma reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Biohaven Pharma announced earnings per share of $-1.25 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-2.11 on revenue of $251.19M.
Biohaven Pharma shares are down 0.45% from the beginning of the year and are trading at $14.98 , down-from-52-week-high.
Biohaven Pharma shares lost 3.79% in intra-day trade the report.
Biohaven Pharma follows other major Healthcare sector earnings this month
Biohaven Pharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar